Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005768,
umls-concept:C0006675,
umls-concept:C0056193,
umls-concept:C0072393,
umls-concept:C0150312,
umls-concept:C0449432,
umls-concept:C1179435,
umls-concept:C1510827,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1704675,
umls-concept:C1705248,
umls-concept:C1705535,
umls-concept:C1998811
|
pubmed:issue |
27
|
pubmed:dateCreated |
1990-10-18
|
pubmed:abstractText |
The anticoagulant vitamin K-dependent protein S interacts with the complement regulatory protein C4b-binding protein (C4BP), both in purified systems and in plasma. The concentrations of these proteins in plasma are approximately equimolar (0.3 microM) and 30-40% of protein S in plasma is found in the noncomplexed state. Only the uncomplexed form of protein S displays anticoagulant activity and studies have shown that patients with a selective deficiency of free protein S have a high incidence of thrombosis. In this study, we report that the protein S-C4BP interaction is at least 100-fold tighter in the presence of Ca2+ than in EDTA. The KD in the presence of Ca2+ was estimated with a gel filtration technique to be less than 5 x 10(-10) M, whereas in the presence of EDTA, it was approximately 100-fold higher. Ca2+ titration experiments suggested that the Ca2+ sites which function in the protein S-C4BP interaction are of high affinity which, in turn, suggests that they may be independent of the gamma-carboxyglutamic acid region and may be present in the epidermal growth factor-like domains of protein S. The high affinity of the protein S-C4BP interaction in the presence of Ca2+ suggested that virtually all of the protein S in whole blood should be complexed with C4BP. However, even though the protein S-C4BP interaction in Ca2(+)-containing serum was shown to have the same high affinity as in purified systems, approximately 30-40% of the protein S in serum was free. These results appear best explained by the presence of a third component in whole blood which regulates the protein S-C4BP interaction, keeping approximately 30-40% of circulating protein S in its free, functionally anticoagulant form. It is speculated that persons with little free protein S may be deficient in this hypothetical third component.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C4b,
http://linkedlifedata.com/resource/pubmed/chemical/Complement Inactivator Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Edetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Protein S
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
265
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16082-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2144524-Calcium,
pubmed-meshheading:2144524-Carrier Proteins,
pubmed-meshheading:2144524-Chromatography, Gel,
pubmed-meshheading:2144524-Complement C4b,
pubmed-meshheading:2144524-Complement Inactivator Proteins,
pubmed-meshheading:2144524-Edetic Acid,
pubmed-meshheading:2144524-Glycoproteins,
pubmed-meshheading:2144524-Humans,
pubmed-meshheading:2144524-Kinetics,
pubmed-meshheading:2144524-Polyethylene Glycols,
pubmed-meshheading:2144524-Protein Binding,
pubmed-meshheading:2144524-Protein S,
pubmed-meshheading:2144524-Thrombosis
|
pubmed:year |
1990
|
pubmed:articleTitle |
High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Suggestion of a third component in blood regulating the interaction.
|
pubmed:affiliation |
Department of Clinical Chemistry, University of Lund, Malmö General Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|